Shandong Lukang Pharmaceutical Co.,Ltd.

SSE:600789.SS

10.9 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993
Revenue 6,233.096,092.9615,621.4424,890.6734,205.1093,732.7193,329.6052,599.2892,505.5922,410.2882,312.1032,210.6852,339.4542,332.8732,196.1451,985.1171,789.4421,462.4111,113.641,155.9361,027.522974.1931,039.48771.137701.322592.742563.448690.619597.519487.369434.544396.541
Cost of Revenue 4,739.4694,685.9514,373.9623,744.1793,224.9772,677.0362,292.4971,889.9171,917.041,935.6141,898.9611,840.9632,014.331,966.571,722.7251,660.5271,483.8181,188.153973.6821,013.403900.05719.192761.085583.843512.068465.659426.349520.085440.401344.758318.466275.957
Gross Profit 1,493.6211,407.011,247.481,146.493980.1321,055.6831,037.108709.372588.552474.674413.142369.723325.125366.303473.42324.59305.624274.257139.958142.533127.471255.001278.395187.295189.254127.083137.099170.534157.118142.611116.078120.584
Gross Profit Ratio 0.240.2310.2220.2340.2330.2830.3110.2730.2350.1970.1790.1670.1390.1570.2160.1640.1710.1880.1260.1230.1240.2620.2680.2430.270.2140.2430.2470.2630.2930.2670.304
Reseach & Development Expenses 317.147345.785275.835254.302192.635140.849125.61596.988109.06445.4137.15828.07425.37624.98220.17500000000000000000
General & Administrative Expenses 48.83956.3844.12654.12746.66341.63835.65833.67638.44740.21252.44567.0725.48421.51423.92989.40681.39280.862113.9681.526122.64285.74673.25545.51338.97326.27738.1939.55833.32336.87825.10528.821
Selling & Marketing Expenses 410.41419.634475.088479.618460.207543.975486.882297.165234.817203.019221.414202.689215.465183.606171.678135.76117.531110.37665.43337.52659.26239.03541.48235.2267.39957.24824.38628.01215.9788.858.7567.697
SG&A 459.249811.191519.214533.745506.871585.613522.539330.841273.264243.231273.858269.758240.948205.12195.607225.166198.924191.238179.393119.051181.904124.781114.73680.732106.37283.52562.57767.5749.30145.72833.86136.519
Other Expenses 281.03631.661159.346124.398121.334107.5625.23810.8319.819.6732.338124.41811.94141.92715.64412.8189.774-1.556-1.7985.2781.2854.6581.7272.556.5713.5962.87913.28613.1131.871.7250.981
Operating Expenses 1,057.4321,188.637954.395912.445820.84834.024747.844503.162505.823413.385434.541417.123364.318318.1292.909237.943209.763199.419187.721126.144186.628131.164123.50586.764112.68786.49665.71873.2851.04646.10636.35572.375
Operating Income 436.19272.133307.668226.901154.775257.502187.076129.12826.4747.46-134.045-114.914-137.837-14.233135.15735.26733.75428.052-95.4292.241-94.77975.406123.93582.51370.3654.63370.081103.71991.93183.92372.43240.385
Operating Income Ratio 0.070.0450.0550.0460.0370.0690.0560.050.0110.003-0.058-0.052-0.059-0.0060.0620.0180.0190.019-0.0860.002-0.0920.0770.1190.1070.10.0920.1240.150.1540.1720.1670.102
Total Other Income Expenses Net -2.2880.842-157.572-113.323-5.205-108.6835.23810.8319.4679.5621.951123.041-43.20441.2855.158-40.785-54.647-5.218-0.782-17.656-38.693.005-2.684-0.519-2.884-0.1140.7717.6868.913-0.309-0.415-0.242
Income Before Tax 433.901272.975150.095106.257262.161148.819192.314139.9636.13717.022-132.0938.127-126.85927.052150.59945.86241.21426.497-96.2113.126-95.6778.41122.99781.99470.42254.51970.851111.405100.84483.61472.01740.143
Income Before Tax Ratio 0.070.0450.0270.0220.0620.040.0580.0540.0140.007-0.0570.004-0.0540.0120.0690.0230.0230.018-0.0860.003-0.0930.080.1180.1060.10.0920.1260.1610.1690.1720.1660.101
Income Tax Expense 25.55416.1886.9822.77928.67620.03218.88211.0326.639.4524.5974.0194.5668.22916.7675.1832.410.3950.3080.0510.05824.2925.37511.53410.6678.2523.38116.83915.1278.03610.8037.851
Net Income 394.616246.172138.01389.099227.877121.251161.387114.23729.1027.897-125.21510.858-133.83415.013129.61137.5835.20525.974-96.5384.977-92.34854.1297.62270.4659.75546.26960.22494.56685.71765.96461.21432.291
Net Income Ratio 0.0630.040.0250.0180.0540.0320.0480.0440.0120.003-0.0540.005-0.0570.0060.0590.0190.020.018-0.0870.004-0.090.0560.0940.0910.0850.0780.1070.1370.1430.1350.1410.081
EPS 0.440.270.160.10.260.140.190.150.0390.008-0.170.015-0.180.0230.170.0460.0460.031-0.170.006-0.110.060.120.0870.0710.0570.0730.130.10.0780.0730.038
EPS Diluted 0.440.270.150.10.250.140.190.150.0390.008-0.170.015-0.180.0230.170.0460.0460.031-0.170.006-0.110.060.120.0870.0710.0570.0730.130.10.0780.0730.038
EBITDA 910.886741.886611.593486.169570.679392.54393.691315.971233.512252.534133.748277.862103.908236.319336.007244.543248.774210.07979.895176.80867.972216.378257.55177.892165.60271.61499.98297.254106.07296.50579.72348.209
EBITDA Ratio 0.1460.1220.1090.0990.1360.1050.1180.1220.0930.1050.0580.1260.0440.1010.1530.1230.1390.1440.0720.1530.0660.2220.2480.2310.2360.1210.1770.1410.1780.1980.1830.122